The estimated Net Worth of Gary E Costley is at least $4.3 Million dollars as of 5 February 2018. Gary Costley owns over 7,500 units of Prestige Consumer Healthcare Inc stock worth over $2,738,547 and over the last 19 years he sold PBH stock worth over $1,309,115. In addition, he makes $249,524 as Lead Independent Director at Prestige Consumer Healthcare Inc.
Sign up
Gary Costley PBH stock SEC Form 4 insiders trading
Gary has made over 14 trades of the Prestige Consumer Healthcare Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 7,500 units of PBH stock worth $266,025 on 5 February 2018.
The largest trade he's ever made was exercising 24,717 units of Prestige Consumer Healthcare Inc stock on 26 September 2012 worth over $998,567. On average, Gary trades about 1,096 units every 24 days since 2005. As of 5 February 2018 he still owns at least 38,506 units of Prestige Consumer Healthcare Inc stock.
You can see the complete history of Gary Costley stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gary Costley biography
Dr. Gary E. Costley is a Lead Independent Director of Prestige Brands Holdings, Inc. Dr. Costley serves as managing partner at C&G Capital and Management, a private investment company, which he joined in July 2004. Dr. Costley also serves as the Chairman of the Board of BlueWillow Biologics, Inc., a private early stage vaccine company. He previously served from 2001 to June 2004 as Chairman and Chief Executive Officer of International Multifoods Corporation and from 1997 to 2001 as its Chairman, President and Chief Executive Officer. From 1995 to 1996, Dr. Costley served as Dean of the Graduate School of Marketing at Wake Forest University. Prior to that time, Dr. Costley spent 24 years with the Kellogg Company, where he held various positions of increasing responsibility, including his most recent role as President of Kellogg North America. Dr. Costley earned a B.S. in Animal Science and both an M.S. and Ph.D. in Nutrition from Oregon State University. Dr. Costley has also served on the boards of Tiffany & Company, Pharmacopeia Inc., Principal Financial Group Inc., Covance Inc. and Accelrys, Inc.
What is the salary of Gary Costley?
As the Lead Independent Director of Prestige Consumer Healthcare Inc, the total compensation of Gary Costley at Prestige Consumer Healthcare Inc is $249,524. There are 10 executives at Prestige Consumer Healthcare Inc getting paid more, with Ronald Lombardi having the highest compensation of $5,051,680.
How old is Gary Costley?
Gary Costley is 55, he's been the Lead Independent Director of Prestige Consumer Healthcare Inc since 2009. There are 11 older and 3 younger executives at Prestige Consumer Healthcare Inc. The oldest executive at Prestige Consumer Healthcare Inc is James Jenness, 73, who is the Independent Director.
Insiders trading at Prestige Consumer Healthcare Inc
Over the last 20 years, insiders at Prestige Consumer Healthcare Inc have traded over $32,224,266 worth of Prestige Consumer Healthcare Inc stock and bought 60,410 units worth $1,162,754 . The most active insiders traders include Matthew Mannelly, James M Jenness, and Dawn M. Zier. On average, Prestige Consumer Healthcare Inc executives and independent directors trade stock every 62 days with the average trade being worth of $2,469,571. The most recent stock trade was executed by Mary Beth Fritz on 1 March 2024, trading 172 units of PBH stock currently worth $6,908.
What does Prestige Consumer Healthcare Inc do?
at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th
What does Prestige Consumer Healthcare Inc's logo look like?
Complete history of Gary Costley stock trades at Prestige Consumer Healthcare Inc, Principal Inc, Tiffany & Co, and Principal Inc
Prestige Consumer Healthcare Inc executives and stock owners
Prestige Consumer Healthcare Inc executives and other stock owners filed with the SEC include:
-
Ronald Lombardi,
Chairman of the Board, President, Chief Executive Officer -
Ronald M. Lombardi,
Chairman, Pres & CEO -
Christine Sacco,
Chief Financial Officer -
William PPool,
Senior Vice President, General Counsel and Corporate Secretary -
Adel Mekhail,
Executive Vice President - Sales and Marketing -
Christine Sacco,
Chief Financial Officer -
Jeffrey Zerillo,
Senior Vice President, Operations -
Adel Mekhail,
Exec. VP of Marketing & Sales -
William C. P'Pool,
Sr. VP, Gen. Counsel & Corp. Sec. -
Jeffrey Zerillo,
Sr. VP of Operations -
Gary Costley,
Lead Independent Director -
John Byom,
Independent Director -
James Jenness,
Independent Director -
Natale Ricciardi,
Independent Director -
Sheila Hopkins,
Independent Director -
Christopher Coughlin,
Independent Director -
Dawn Zier,
Independent Director -
Mary Beth Fritz,
Sr. VP of Quality & Regulatory Affairs -
Dean Siegal,
Director of Communications -
Philip David Terpolilli,
Director of Investor Relations -
John F. Kelly,
Director -
Lieven Nuyttens,
Senior VP, Operations -
Partners Viii L Pgtcr Golde...,
-
Paul Migaki,
VP Strategic Planning/Canada -
Thomas Hochuli,
Vice President, Operations -
David S Marberger,
Chief Financial Officer -
Timothy Connors,
Chief Marketing Officer -
John Parkinson,
Senior VP- International -
Christopher Heye,
See remarks -
Carl J Johnson,
Director -
Samuel C Cowley,
General Counsel, VP Bus. Dev. -
James E Kelly,
Senior VP - Marketing -
Mark Pettie,
Chairman of the Board and CEO -
Ronald B Gordon,
Director -
Charles Schrank,
Senior V.P. of Marketing -
Peter Anderson,
Chief Financial Officer -
David Talbert,
Senior Vice President, Sales -
Gerard Butler,
Chief Sales Officer -
Co Invest Ii Lpgtcr Golder ...,
-
Fund Viii Lpgtcr Partners V...,
-
Jean A Boyko,
SVP, Quality & Reg. Affairs -
John Byom,
Director -
Eric S. Klee,
Secretary and General Counsel -
Peter Mann,
Chief Executive Officer -
L Dick Buell,
Director -
Mezzanine Partners Lpgtcr P...,
-
Frank Palantoni,
President and COO -
Eric Millar,
Senior V.P. of Operations -
Charles Hinkaty,
Director -
Matthew Mannelly,
President and CEO -
Michael Fink,
Senior V.P. of Marketing -
Raymond Silcock,
Director -
Paul A. Hennessey,
Vice President, Operations -
Patrick Lonergan,
Director -
Vincent J Hemmer,
Director -
Mezzanine Partners Lpgtcr G...,
-
Fund Viii/B L Pgtcr Partner...,
-
Golder Rauner Ii Llc Gtcr,
10% owner -
Capital Partners L Pgtcr Me...,
-
David Donnini,
Director -
Charles Jolly,
Secretary & General Counsel -
Celeste A. Clark,
Director -
James D Arecca,
Director -
William P'pool,
See Remarks -
Mary Beth Fritz,
SVP Quality & Regulatory